NVCT · Categories · Form 4

NVCT - SEC Form 4 insider transactions

Nuvectis Pharma Inc. (NVCT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for NVCT

• 107d
  Chief Dev. & Ops. Officer Shemesh Shay was granted 150,000 shares, increasing direct ownership by 9% to 1,793,068 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 107d
  Chairman & CEO Bentsur Ron was granted 150,000 shares, increasing direct ownership by 4% to 3,675,924 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 107d
  Chief Science & Business Off Poradosu Enrique was granted 150,000 shares, increasing direct ownership by 9% to 1,806,319 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 107d
  Vice President, Finance Carson Michael J. was granted 61,200 shares, increasing direct ownership by 44% to 200,118 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 177d
  Director Sanchez Juan was granted 30,000 shares, increasing direct ownership by 85% to 65,150 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 318d
  Director Kaplan Matthew L. was granted 30,000 shares, increasing direct ownership by 36% to 113,760 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 318d
  Director Oliviero James F Iii was granted 30,000 shares, increasing direct ownership by 52% to 87,828 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 318d
  Director Hoberman Kenneth was granted 30,000 shares, increasing direct ownership by 29% to 133,140 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 478d
  Chief Dev. & Ops. Officer Shemesh Shay was granted 150,000 shares, increasing direct ownership by 10% to 1,643,068 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 478d
  Chief Science & Business Off Poradosu Enrique was granted 150,000 shares, increasing direct ownership by 10% to 1,656,319 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 478d
  Vice President, Finance Carson Michael J. was granted 51,000 shares, increasing direct ownership by 58% to 138,918 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 478d
  Chairman & CEO Bentsur Ron was granted 250,000 shares, increasing direct ownership by 8% to 3,520,924 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 534d
  Vice President, Finance Carson Michael J. sold $22,478 worth of shares (2,755 units at $8.16) and was granted 63,373 shares, increasing direct ownership by 222% to 87,918 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 682d
  Director Kaplan Matthew L. was granted 30,000 shares, increasing direct ownership by 56% to 83,760 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 682d
  Director Hoberman Kenneth was granted 30,000 shares, increasing direct ownership by 41% to 103,140 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 682d
  Director Oliviero James F Iii was granted 30,000 shares, increasing direct ownership by 108% to 57,828 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 842d
  Poradosu Enrique was granted 130,000 shares, increasing direct ownership by 9% to 1,503,819 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 842d
  Shemesh Shay was granted 130,000 shares, increasing direct ownership by 10% to 1,491,955 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 984d
  SEC Form 4: Bentsur Ron bought $5,112 worth of shares (350 units at $14.61), increasing direct ownership by 0.01% to 3,232,544 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 989d
  SEC Form 4: Bentsur Ron bought $4,418 worth of shares (300 units at $14.73), increasing direct ownership by 0.01% to 3,232,194 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 999d
  SEC Form 4: Mosseri Marlio Charles bought $11,937 worth of shares (860 units at $13.88), increasing direct ownership by 0.03% to 2,595,000 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1000d
  SEC Form 4: Mosseri Marlio Charles bought $35,943 worth of shares (2,584 units at $13.91), increasing direct ownership by 0.10% to 2,594,140 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1003d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1004d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1007d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1007d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1011d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1011d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1012d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1013d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1018d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1019d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1021d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1024d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1024d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1025d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1034d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1034d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1035d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1038d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1039d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1041d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1041d
  SEC Form 4 filed by Oliviero James F Iii

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1041d
  SEC Form 4 filed by Kaplan Matthew L.

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1041d
  SEC Form 4 filed by Hoberman Kenneth

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1045d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1053d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1060d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1066d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1074d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1125d
  SEC Form 4 filed by Poradosu Enrique

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1126d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1130d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1131d
  SEC Form 4 filed by Shemesh Shay

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1136d
  SEC Form 4: Shemesh Shay bought $7,176 worth of shares (670 units at $10.71), increasing direct ownership by 0.05% to 1,361,535 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1137d
  SEC Form 4: Bentsur Ron bought $23,465 worth of shares (2,160 units at $10.86), increasing direct ownership by 0.07% to 3,227,619 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1199d
  SEC Form 4: Poradosu Enrique was granted 115,000 shares, increasing direct ownership by 9% to 1,373,319 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1199d
  SEC Form 4: Bentsur Ron was granted 210,000 shares, increasing direct ownership by 7% to 3,225,459 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1199d
  SEC Form 4: Shemesh Shay was granted 115,000 shares, increasing direct ownership by 9% to 1,360,865 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1221d
  SEC Form 4: Shemesh Shay bought $3,825 worth of shares (500 units at $7.65), increasing direct ownership by 0.04% to 1,245,865 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)

Other NVCT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends